Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Arvinas to Present Preclinical Tau-Direc...||07/18/19|
|NEW HAVEN, Conn., July 18, 2019 -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degra...|
|Date||04/12/2019 (AMC)||Est. (EPS/Rev.)||$1.37|
|Actual (EPS/Rev.)||$2.5B||EPS (TTM)||$???|